1. Block G A , Klassen P S , Lazarus J M , et al. Mineral Metabolism, Mortality, and Morbidity in Maintenance Hemodialysis[J]. Journal of the American Society of Nephrology Jasn, 2004, 15(8):2208-2218.
2. Ketteler M , Block G A , Evenepoel P , et al. Executive summary of the 2017 KDIGO Chronic Kidney Disease–Mineral and Bone Disorder (CKD-MBD) Guideline Update: what’s changed and why it matters[J]. Kidney International, 2017, 92(1):26.
3. Slatopolsky E , Finch J , Denda M , et al. Phosphorus restriction prevents parathyroid gland growth. High phosphorus directly stimulates PTH secretion in vitro.[J]. Journal of Clinical Investigation, 1996, 97(11):2534-2540.
4. Komaba H , Fukagawa M . FGF23–parathyroid interaction: implications in chronic kidney disease[J]. Kidney International, 2010, 77(4):292-298.
5. Goto S , Komaba H , Fukagawa M . Pathophysiology of parathyroid hyperplasia in chronic kidney disease: preclinical and clinical basis for parathyroid intervention[J]. Ndt Plus, 2008, 1(Suppl 3):iii2-iii8.
6. John C , Francesco L , Mariano R . Secondary hyperparathyroidism: pathogenesis, disease progression, and therapeutic options[J]. Clinical Journal of the American Society of Nephrology Cjasn, 2011, 6(4):913-21.
7. El-Husseini A , Wang K , Edon A A , et al. Parathyroidectomy-A last resort for hyperparathyroidism in dialysis patients[C]// Seminars in Dialysis. 2017. Sep;30(5):385-389.
8. Lau W L , Kalantar-Zadeh K , Kovesdy C P , et al. Alkaline phosphatase: Better than PTH as a marker of cardiovascular and bone disease?[J]. Hemodialysis International, 2014, 18(4):720-724.
9. Neves K R , Graciolli F G , Reis L M D , et al. Vascular calcification: Contribution of parathyroid hormone in renal failure[J]. Kidney International, 2007, 71(12):1262-1270.
10. Rudser K D , de Boer I H , Dooley A , et al. Fracture risk after parathyroidectomy among chronic hemodialysis patients.[J]. Journal of the American Society of Nephrology, 2007, 18(8):2401-7.
11. Shao J S , Cheng S L , Charlton-Kachigian N , et al. Teriparatide (Human Parathyroid Hormone (1-34)) Inhibits Osteogenic Vascular Calcification in Diabetic Low Density Lipoprotein Receptor-deficient Mice[J]. Journal of Biological Chemistry, 2003, 278(50):50195-50202.
12. Bielesz B , Reiter T , Marculescu R , et al. Calcification Propensity of Serum is Independent of Excretory Renal Function[J]. Sci Rep, 2017, 7(1).
13. Shantouf R , Kovesdy C P , Kim Y , et al. Association of serum alkaline phosphatase with coronary artery calcification in maintenance hemodialysis patients[J]. Clinical Journal of the American Society of Nephrology Cjasn, 2009, 4(6):1106.
14. Mccarthy J T , Elazhary R A , Patzelt M T , et al. Survival, Risk Factors, and Effect of Treatment in 101 Patients With Calciphylaxis[J]. Mayo Clinic Proceedings, 2016, 91(10):1384-1394.
15. Gallieni M , Corsi C , Brancaccio D . Hyperparathyroidism and Anemia in Renal Failure[J]. American Journal of Nephrology, 2000, 20(2):89-96.
16. Komaba H , Nakamura M , Fukagawa M . Resurgence of parathyroidectomy: evidence and outcomes[J]. Current Opinion in Nephrology & Hypertension, 2017, 26(4):243.
17. Schneider R , Slater E P , Karakas E , et al. Initial parathyroid surgery in 606 patients with renal hyperparathyroidism.[J]. World Journal of Surgery, 2012, 36(2):318-26.
18. Tilman B Drüeke, Ritz E . Treatment of secondary hyperparathyroidism in CKD patients with cinacalcet and/or vitamin D derivatives[J]. Clinical Journal of the American Society of Nephrology Cjasn, 2009, 4(1):234.
19. 周加军,张凌.活性维生素D及其类似物在CKD-MBD中的应用[J].中国血液净化,2018,17 (06): 370-373.
20. 张凌.继发性甲状旁腺功能亢进的治疗策略[J].中华肾病研究电子杂志,2015,4(03):118-122.
21. Chen J, Jia X, Kong X, et al: Total parathyroidectomy with autotransplantation versus subtotal parathyroidectomy for renal hyperparathyroidism: A systematic review and meta-analysis[J]. Nephrology (Carlton), 2017, 22(5):388-396.
22. Qiu N C , Zha S L , Liu M E , et al. To assess the effects of parathyroidectomy (TPTX versus TPTX+AT) for Secondary Hyperparathyroidism in chronic renal failure: A meta-analysis[J]. International Journal of Surgery, 2017, 44:353.
23. Li C, Lv L, Wang H, et al. Total parathyroidectomy versus total parathyroidectomy with autotransplantation for secondary hyperparathyroidism: systematic review and meta-analysis.[J]. Ren Fail, 2017, 39(1):678-687.
24. Jr A K , Ruel E , Adam M A , et al. Subtotal vs. total parathyroidectomy with autotransplantation for patients with renal hyperparathyroidism have similar outcomes.[J]. American Journal of Surgery, 2017, 214(5):914.
25. Tominaga Y , Kakuta T , Yasunaga C , et al. Evaluation of Parathyroidectomy for Secondary and Tertiary Hyperparathyroidism by the Parathyroid Surgeons’ Society of Japan[J]. Therapeutic Apheresis and Dialysis, 2016, 20(1):6-11.
26. Kim S M , Long J , Montezrath M E , et al. Rates and Outcomes of Parathyroidectomy for Secondary Hyperparathyroidism in the United States.[J]. Clinical Journal of the American Society of Nephrology Cjasn, 2016, 11(7):1260.
27. Tentori F , Wang M , Bieber B A , et al. Recent changes in therapeutic approaches and association with outcomes among patients with secondary hyperparathyroidism on chronic hemodialysis: the DOPPS study.[J]. Clin J Am Soc Nephrol, 2015, 10(1):98-109.
28. Chen L , Wang K , Yu S , et al. Long–term mortality after parathyroidectomy among chronic kidney disease patients with secondary hyperparathyroidism: a systematic review and meta-analysis[J]. Renal Failure, 2016:1-9.
29. Apetrii M , Goldsmith D , Nistor I , et al. Impact of surgical parathyroidectomy on chronic kidney disease-mineral and bone disorder (CKD-MBD) – A systematic review and meta-analysis:[J]. Plos One, 2017, 12(11):e0187025.
30. JESúS MONTENEGRO, Cornago I , Gallardo I , et al. Efficacy and safety of cinacalcet for the treatment of secondary hyperparathyroidism in patients with advanced chronic kidney disease before initiation of regular dialysis[J]. Nephrology (Carlton, Vic.), 2012, 17(1):26-31.
31. Jürgen Fl?ge, Kim J , Fouqueray B , et al. Serum iPTH, calcium and phosphate, and the risk of mortality in a European haemodialysis population[J]. Nephrology Dialysis Transplantation, 2011, 26(6):1948-1955.
32. Tentori F , Wang M , Bieber B A , et al. Recent changes in therapeutic approaches and association with outcomes among patients with secondary hyperparathyroidism on chronic hemodialysis: the DOPPS study[J]. Clin J Am Soc Nephrol, 2015, 10(1):98-109.
33. Komaba H , Taniguchi M , Wada A , et al. Parathyroidectomy and survival among Japanese hemodialysis patients with secondary hyperparathyroidism[J]. Kidney International, 2015, 88(2):350-359.
34. Solbiati L, Giangrande A, De Pra L , et al: Percutaneous ethanol injection of parathyroid tumors under US guidance: treatment for secondary hyperparathyroidism. Radiology 1985, 155(3):607-610.
35. Sharon M , Pradhan D , Zacharia R , et al. Application of Carbon Nanomaterial as a Microwave Absorber[J]. J Nanosci Nanotechnol, 2005, 5(12):2117-2120.
36. 张凌, 卞维静, 程虹, 等: 超声引导下甲状旁腺无水酒精注射治疗继发性甲状旁腺功能亢进症[J]. 中华内科杂志 2001, 40(11):775-777.
37. Koiwa F , Kakuta T , Tanaka R , et al. Efficacy of percutaneous ethanol injection therapy (PEIT) is related to the number of parathyroid glands in haemodialysis patients with secondary hyperparathyroidism[J]. Nephrology Dialysis Transplantation, 2006, 22(2):522-528.
38. 罗洋, 张凌, 卞维静, 等: 经皮乙醇注射治疗血液透析继发甲状旁腺机能亢进症远期预后研究[J]. 中日友好医院学报 2007, 21(6):333-335.
39. 彭成忠, 陈洪宇, 张正贤, 等: 射频消融术治疗慢性肾脏病继发甲状旁腺功能亢进[J]. 中华肾脏病杂志 2014, 30(11):870-871.
40. 章建全, 仇明, 盛建国, 等: 超声引导下经皮穿刺热消融治疗甲状旁腺结节[J]. 第二军医大学学报 2013, 34(4):362-370.
41. 于明安, 张凌, 彭丽丽, 等: 超声引导微波消融术治疗继发性甲旁亢短期疗效分析[J]. 中华肾脏病杂志 2015, 31(4):303-304.
42. Peng C, Zhang Z, Liu J , et al: Efficacy and safety of ultrasound-guided radiofrequency ablation of hyperplastic parathyroid gland for secondary hyperparathyroidism associated with chronic kidney disease[J]. Head & neck 2017, 39(3):564-571.
